XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Balance at Dec. 31, 2020 $ 8,726 $ 148 $ 431,544 $ (422,975) $ 9
Balance (in shares) at Dec. 31, 2020   148,078,974      
Stock-based compensation expense 1,308   1,308    
Issuance of common stock from vesting of restricted stock and exercise of stock options 53   53    
Issuance of common stock from vesting of restricted stock and exercise of stock options (in shares)   412,699      
Unrealized gain (loss) on marketable securities 7       7
Net loss (10,660)     (10,660)  
Balance at Mar. 31, 2021 (566) $ 148 432,905 (433,635) 16
Balance (in shares) at Mar. 31, 2021   148,491,673      
Balance at Dec. 31, 2021 $ (12,903) $ 166 459,151 (472,216) (4)
Balance (in shares) at Dec. 31, 2021 166,400,892 166,400,892      
Stock-based compensation expense $ 2,552   2,552    
Issuance of common stock from vesting of restricted stock and exercise of stock options   $ 2 (2)    
Issuance of common stock from vesting of restricted stock and exercise of stock options (in shares)   2,002,048      
Surrender of shares due to tax withholding (230) $ (1) (229)    
Surrender of shares due to tax withholding (in shares)   (539,360)      
Issuance of common stock from secondary offering, net 1,432 $ 4 1,428    
Issuance of common stock from secondary offering, net (in shares)   3,549,360      
Unrealized gain (loss) on marketable securities (7)       (7)
Net loss (16,495)     (16,495)  
Balance at Mar. 31, 2022 $ (25,651) $ 171 $ 462,900 $ (488,711) $ (11)
Balance (in shares) at Mar. 31, 2022 171,412,940 171,412,940